The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Biallelic Mutations in BRCA1 Cause a New Fanconi Anemia Subtype
Open accessPublished version of a preprint
Abstract
Deficiency in BRCA-dependent DNA interstrand crosslink (ICL) repair is intimately connected to breast cancer susceptibility and to the rare developmental syndrome Fanconi anemia. Bona fide Fanconi anemia proteins, BRCA2 (FANCD1), PALB2 (FANCN), and BRIP1 (FANCJ), interact with BRCA1 during ICL repair. However, the lack of detailed phenotypic and cellular characterization of a patient with biallelic BRCA1 mutations has precluded assignment of BRCA1 as a definitive Fanconi anemia susceptibility gene. Here, we report the presence of biallelic BRCA1 mutations in a woman with multiple congenital anomalies consistent with a Fanconi anemia–like disorder and breast cancer at age 23. Patient cells exhibited deficiency in BRCA1 and RAD51 localization to DNA-damage sites, combined with radial chromosome formation and hypersensitivity to ICL-inducing agents. Restoration of these functions was achieved by ectopic introduction of a BRCA1 transgene. These observations provide evidence in support of BRCA1 as a new Fanconi anemia gene (FANCS). Significance: We establish that biallelic BRCA1 mutations cause a distinct FA-S, which has implications for risk counselling in families where both parents harbor BRCA1 mutations. The genetic basis of hereditary cancer susceptibility syndromes provides diagnostic information, insights into treatment strategies, and more accurate recurrence risk counseling to families. Cancer Discov; 5(2); 135–42. ©2014 AACR. This article is highlighted in the In This Issue feature, p. 97
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy
Farmer, H., McCabe, N., Lord, C. J., Tutt, A. N. J., Johnson, D. A., Richardson, T. B., Santarosa, M., Dillon, K. J., Hickson, I., Knights, C., et al. (2005) · Nature · doi:10.1038/nature03445 · Cited by 6,683
Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase
Bryant, H. E., Schultz, N., Thomas, H. D., Parker, K. M., Flower, D., Lopez, E., Kyle, S., Meuth, M., Curtin, N. J., & Helleday, T. (2005) · Nature · doi:10.1038/nature03443 · Cited by 5,198
Biallelic Inactivation of BRCA2 in Fanconi Anemia
Howlett, N. G., Taniguchi, T., Olson, S., Cox, B., Waisfisz, Q., de Die-Smulders, C., Persky, N., Grompe, M., Joenje, H., Pals, G., et al. (2002) · Science · doi:10.1126/science.1073834 · Cited by 1,149
The Fanconi anaemia/BRCA pathway
D'Andrea, A. D., & Grompe, M. (2003) · Nature Reviews Cancer · doi:10.1038/nrc970 · Cited by 822
Emergence of a DNA-damage response network consisting of Fanconi anaemia and BRCA proteins
Wang, W. (2007) · Nature Reviews Genetics · doi:10.1038/nrg2159 · Cited by 663
Biallelic mutations in PALB2 cause Fanconi anemia subtype FA-N and predispose to childhood cancer
Reid, S., Schindler, D., Hanenberg, H., Barker, K., Hanks, S., Kalb, R., Neveling, K., Kelly, P., Seal, S., Freund, M., et al. (2007) · Nature Genetics · doi:10.1038/ng1947 · Cited by 642
Fanconi anemia is associated with a defect in the BRCA2 partner PALB2
Xia, B., Dorsman, J. C., Ameziane, N., de Vries, Y., Rooimans, M. A., Sheng, Q., Pals, G., Errami, A., Gluckman, E., Llera, J., et al. (2007) · Nature Genetics · doi:10.1038/ng1942 · Cited by 465
Mutation of the RAD51C gene in a Fanconi anemia–like disorder
Vaz, F., Hanenberg, H., Schuster, B., Barker, K., Wiek, C., Erven, V., Neveling, K., Endt, D., Kesterton, I., Autore, F., et al. (2010) · Nature Genetics · doi:10.1038/ng.570 · Cited by 408 · cited 1×
“10 patients had either breast or ovarian cancer, but did not develop bone marrow failure, which is similar to the FA-O (RAD51C) complementation group (21-23).”
Research works printed but not linked: 18
- Kottemann, 2013, Fanconi anaemia and the repair of Watson and Crick DNA crosslinks, Nature, 493, 356, 10.1038/nature11863 · DOI · Paper page
- Garaycoechea, 2014, Why does the bone marrow fail in Fanconi anemia?, Blood, 123, 26, 10.1182/blood-2013-09-427740 · DOI · Paper page
- Long, 2011, Mechanism of RAD51-dependent DNA interstrand cross-link repair, Science, 333, 84, 10.1126/science.1204258 · DOI · Paper page
- Raschle, 2008, Mechanism of replication-coupled DNA interstrand crosslink repair, Cell, 134, 969, 10.1016/j.cell.2008.08.030 · DOI · Paper page
- Long, 2014, BRCA1 promotes unloading of the CMG helicase from a stalled DNA replication fork, Mol Cell, 56, 174, 10.1016/j.molcel.2014.08.012 · DOI
- Bunting, 2012, BRCA1 functions independently of homologous recombination in DNA interstrand crosslink repair, Mol Cell, 46, 125, 10.1016/j.molcel.2012.02.015 · DOI · Paper page
- Domchek, 2013, Biallelic deleterious BRCA1 mutations in a woman with early-onset ovarian cancer, Cancer Discov, 3, 399, 10.1158/2159-8290.CD-12-0421 · DOI
- Carvalho, 2014, Probing structure-function relationships in missense variants in the carboxy-terminal region of BRCA1, PLoS ONE, 9, e97766, 10.1371/journal.pone.0097766 · DOI
- Spurdle, 2012, BRCA1 R1699Q variant displaying ambiguous functional abrogation confers intermediate breast and ovarian cancer risk, J Med Genet, 49, 525, 10.1136/jmedgenet-2012-101037 · DOI
- Vallon-Christersson, 2001, Functional analysis of BRCA1 C-terminal missense mutations identified in breast and ovarian cancer families, Hum Mol Genet, 10, 353, 10.1093/hmg/10.4.353 · DOI · Paper page
- Coquelle, 2011, Impact of BRCA1 BRCT domain missense substitutions on phosphopeptide recognition, Biochemistry, 50, 4579, 10.1021/bi2003795 · DOI
- Auerbach, 2009, Fanconi anemia and its diagnosis, Mut Res, 668, 4, 10.1016/j.mrfmmm.2009.01.013 · DOI · Paper page
- Abbott, 1999, BRCA1 expression restores radiation resistance in BRCA1-defective cancer cells through enhancement of transcription-coupled DNA repair, J Biol Chem, 274, 18808, 10.1074/jbc.274.26.18808 · DOI · Paper page
- Meindl, 2010, Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene, Nat Genet, 42, 410, 10.1038/ng.569 · DOI · Paper page
- Loveday, 2012, Germline RAD51C mutations confer susceptibility to ovarian cancer, Nat Genet, 44, 475, 10.1038/ng.2224 · DOI · Paper page
- Li, 2009, Fast and accurate short read alignment with Burrows-Wheeler transform, Bioinformatics, 25, 1754, 10.1093/bioinformatics/btp324 · DOI · Paper page
- DePristo, 2011, A framework for variation discovery and genotyping using next-generation DNA sequencing data, Nat Genet, 43, 491, 10.1038/ng.806 · DOI · Paper page
- McLaren, 2010, Deriving the consequences of genomic variants with the Ensembl API and SNP Effect Predictor, Bioinformatics, 26, 2069, 10.1093/bioinformatics/btq330 · DOI · Paper page
Cited by
Germline Mutations in Predisposition Genes in Pediatric Cancer
Zhang, J., Walsh, M. F., Wu, G., Edmonson, M. N., Gruber, T. A., Easton, J., Hedges, D., Ma, X., Zhou, X., Yergeau, D. A., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1508054 · Cited by 1,345
Daly, M. B., Pal, T., Berry, M. P., Buys, S. S., Dickson, P., Domchek, S. M., Elkhanany, A., Friedman, S., Goggins, M., Hutton, M. L., et al. (2021) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2021.0001 · Cited by 1,112
Homologous Recombination and Human Health: The Roles of BRCA1, BRCA2, and Associated Proteins
Prakash, R., Zhang, Y., Feng, W., & Jasin, M. (2015) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a016600 · Cited by 869
The Fanconi anaemia pathway: new players and new functions
Ceccaldi, R., Sarangi, P., & D'Andrea, A. D. (2016) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2016.48 · Cited by 720
BRCA1–BARD1 promotes RAD51-mediated homologous DNA pairing
Zhao, W., Steinfeld, J. B., Liang, F., Chen, X., Maranon, D. G., Jian Ma, C., Kwon, Y., Rao, T., Wang, W., Sheng, C., et al. (2017) · Nature · doi:10.1038/nature24060 · Cited by 393
Metadata
- Authors
- Sawyer, S. L., Tian, L., Kähkönen, M., Schwartzentruber, J., Kircher, M., University of Washington Centre for Mendelian Genomics, FORGE Canada Consortium, Majewski, J., Dyment, D. A., Innes, A. M., Boycott, K. M., Moreau, L. A., Moilanen, J. S., & Greenberg, R. A.
- Venue
- Cancer Discovery
- Published
- 2015-02-01
- Volume
- 5
- Issue
- 2
- Pages
- 135-142
- ISSN
- 2159-8274 (ISSN-L)
- 2159-8290
- OpenAlex
- W2137273906
- Cited by
- 283
- References
- 8
- FWCI
- 14.84
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Biallelic Mutations in BRCA1 Cause a New Fanconi Anemia Subtype. https://app.cochat.ai/papers/10.1158/2159-8290.cd-14-1156
- The paper
- Sawyer, S. L., Tian, L., Kähkönen, M., Schwartzentruber, J., Kircher, M., University of Washington Centre for Mendelian Genomics, FORGE Canada Consortium, Majewski, J., Dyment, D. A., Innes, A. M., Boycott, K. M., Moreau, L. A., Moilanen, J. S., & Greenberg, R. A. (2015). Biallelic Mutations in BRCA1 Cause a New Fanconi Anemia Subtype. Cancer Discovery. https://doi.org/10.1158/2159-8290.cd-14-1156
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.